launch

All the 22 Drugs Approved by FDA in 2016 and All the New Launches

In 2016, the Center for Drug Evaluation and Research (CDER) of FDA approved 22 novel drugs. This represents a significant slowdown compared to the 45 new medications in 2015 and 41 in 2014. Despite the negative trend of approval over the past few years, we are still going to see many launches in 2017. Here … Continue reading All the 22 Drugs Approved by FDA in 2016 and All the New Launches

Advertisements
Best Selling Oncology Drugs 2016 - Igeahub - Luca Dezzani

Best Selling Oncology Drugs 2016

The top-ten oncology drugs accounted for 36% of the total oncology drugs market. The list is headed by Avastin, an oncology product manufactured by Roche

Fastest Growing Pharmaceutical Classes Today and Beyond - Igeahub.com

Fastest Growing Pharmaceutical Classes Today and Beyond

With the increasing prevalence of different health conditions requiring expensive lifelong treatment, the global sales of therapeutics have been expected to skyrocket in the coming years. In the year 2015, pharmaceutical spending in the United States has reached 1 112.2 USD per capita. This covers expenditures on both prescription medicines as well as self-medication or … Continue reading Fastest Growing Pharmaceutical Classes Today and Beyond

Biosimilars

Biosimilar Products and Its Commercial Potential

The increasing demand for medicines and other biologic products paved the way to the development of methods that can speed up its production in order to meet the needs of its consumers. One of which is the utilization of biosimilar product, which is defined by the U.S. Food and Drug Administration (FDA) as ‘a biological … Continue reading Biosimilar Products and Its Commercial Potential

Orphan Drugs - Igea - Luca Dezzani

Top 10 Orphan Drugs and Their Economic Power

Rare diseases are known to bring significant impact on the quality of life of thousands to millions of people across the globe. Rare diseases are also referred to as orphan diseases because pharmaceutical companies refuse to adopt them to develop treatments. In fact, according to the National Center for Advancing Translational Sciences, there are approximately … Continue reading Top 10 Orphan Drugs and Their Economic Power

best selling drugs

Top 25 Pharmaceutical Products in 2015

The prescription drugs market includes a large number of formulation products that address a diverse array of therapeutic requirements. Prescription drugs have life-cycle that is distinguished by high sales revenues during the patent-protected period. The parent companies invest in sales and marketing of the products to maximize their return on investment on research and development. … Continue reading Top 25 Pharmaceutical Products in 2015

World’s Top Ten Cancer Drugs by 2020

World’s Top Ten Cancer Drugs by 2020

According to the World Health Organization, around 8.2 million people die from cancer every year and it comprises an estimated 13% of all deaths worldwide. It is also predicted by the WHO that there will be a 70% increase in new cases of cancer in the next two decades. Fortunately, many pharma and biotech companies … Continue reading World’s Top Ten Cancer Drugs by 2020

Immuno-Oncology News

Immuno-Oncology Upcoming Immunotherapies

February 9, 2016 Phase 1 Study of Second Generation Non-Viral CD19-Specific CAR T-Cell Therapy for Advanced Lymphoid Malignancies ZIOPHARM Oncology, a biopharmaceutical company focused on new cancer immunotherapies. They announced that the first patient has been enrolled in a Phase 1 clinical study of its second generation non-viral CD19-specific chimeric antigen receptor (CAR) modified T-cell … Continue reading Immuno-Oncology Upcoming Immunotherapies